Clinical Trial Update: Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Kunamin in SARS-CoV-2 PCR-positive COVID-19 patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Pneumonia

Drugs mentioned

• Kunamin

Snippet

Sponsor: RAAS Nutritionals, LLC | Conditions: COVID-19 Respiratory Infection, FLU | Phase 3 | Status: COMPLETED